VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc., a privately held computational biotechnology company, today announced it has added Dr. C. Geoffrey Davis of Angelica Therapeutics, and Dr. Mihaly Mezei of Mount Sinai School of Medicine to its scientific advisory board.
